The University of Southampton
University of Southampton Institutional Repository

Distribution of molecular subtypes in muscle-invasive bladder cancer is driven by sex-specific differences

Distribution of molecular subtypes in muscle-invasive bladder cancer is driven by sex-specific differences
Distribution of molecular subtypes in muscle-invasive bladder cancer is driven by sex-specific differences

Muscle-invasive bladder cancer (MIBC) is a sex-biased cancer with a higher incidence in men but worse outcomes in women. The root cause behind these observations remains unclear. To investigate whether sex-specific tumor biology could explain the differences in clinical behavior of MIBC, we analyzed the transcriptome profiles from transurethral resected bladder tumors of 1000 patients. Female tumors expressed higher levels of basal- and immune-associated genes, while male tumors expressed higher levels of luminal markers. Using molecular subtyping, we found that the rates of the basal/squamous subtype were higher in females than in males. Males were enriched with tumors of the luminal papillary (LumP) and neuroendocrine-like subtypes. Male MIBC tumors had higher androgen response activity across all luminal subtypes and male patients with LumP tumors were younger. Taken together, these data confirm differences in molecular subtypes based on sex. The role of the androgen response pathway in explaining subtype differences between men and women should be studied further.

PATIENT SUMMARY: We explored the sex-specific biology of bladder cancer in 1000 patients and found that women had more aggressive cancer with higher immune activity. Men tended toward less aggressive tumors that showed male hormone signaling, suggesting that male hormones may influence the type of bladder cancer that a patient develops.

Bladder cancer, Gene expression, Molecular subtypes, Sex specific
420-423
de Jong, Joep J.
c8631e1b-fd90-421d-89db-37ef1cc2fba3
Boormans, Joost L.
4f22065e-656b-4d5e-8e5f-9b5812158c51
van Rhijn, Bas W.G.
210224fd-2a7d-4e84-8d1c-4e3731e04af3
Seiler, Roland
dea9a9c3-49d9-438c-b611-f558058de347
Boorjian, Stephen A.
a9b1365f-f314-4279-b796-0d789b4ffda0
Konety, Badrinath
b2dde5b3-0996-4b9c-a2a1-59baccd020f0
Bivalacqua, Trinity J.
a4ae160c-fc52-4e5c-8897-7a4083b7e544
Wheeler, Thomas
1e8d6bf1-8450-4cdc-899a-58d9c6703155
Svatek, Robert S.
606f20dd-2218-4af3-b296-2378f7f00c6e
Douglas, James
113c1170-c37f-46bc-9d1c-38843b080abe
Wright, Jonathan
3cd14a67-a9b0-463f-bdd1-095cb1cfa4ce
Dall'Era, Marc
5236d9b8-175e-4fe0-abea-f24bc77030c5
Crabb, Simon J.
bcd1b566-7677-4f81-8429-3ab0e85f8373
Efstathiou, Jason A
a1afa828-a532-4237-acee-c2f9ad701129
van der Heijden, Michiel S.
70ee9b04-1371-4eb8-8f9e-4f24b4c9101d
Mouw, Kent W.
470c0323-f94a-46fc-af34-9bf48965c7c7
Miyamoto, David T.
926b4f68-87bd-4a7e-8a7b-c77731c76bae
Lotan, Yair
31675425-4fe7-429a-9292-eb2bd19dad5a
Black, Peter C.
16f69c4b-5aa2-43b8-b179-a5ca2856bb69
Gibb, Ewan A.
0f360aa2-3f90-4f79-9746-00ed593e521e
Porten, Sima P.
8634a772-4d13-486a-82b1-f3f8c0f43ae4
de Jong, Joep J.
c8631e1b-fd90-421d-89db-37ef1cc2fba3
Boormans, Joost L.
4f22065e-656b-4d5e-8e5f-9b5812158c51
van Rhijn, Bas W.G.
210224fd-2a7d-4e84-8d1c-4e3731e04af3
Seiler, Roland
dea9a9c3-49d9-438c-b611-f558058de347
Boorjian, Stephen A.
a9b1365f-f314-4279-b796-0d789b4ffda0
Konety, Badrinath
b2dde5b3-0996-4b9c-a2a1-59baccd020f0
Bivalacqua, Trinity J.
a4ae160c-fc52-4e5c-8897-7a4083b7e544
Wheeler, Thomas
1e8d6bf1-8450-4cdc-899a-58d9c6703155
Svatek, Robert S.
606f20dd-2218-4af3-b296-2378f7f00c6e
Douglas, James
113c1170-c37f-46bc-9d1c-38843b080abe
Wright, Jonathan
3cd14a67-a9b0-463f-bdd1-095cb1cfa4ce
Dall'Era, Marc
5236d9b8-175e-4fe0-abea-f24bc77030c5
Crabb, Simon J.
bcd1b566-7677-4f81-8429-3ab0e85f8373
Efstathiou, Jason A
a1afa828-a532-4237-acee-c2f9ad701129
van der Heijden, Michiel S.
70ee9b04-1371-4eb8-8f9e-4f24b4c9101d
Mouw, Kent W.
470c0323-f94a-46fc-af34-9bf48965c7c7
Miyamoto, David T.
926b4f68-87bd-4a7e-8a7b-c77731c76bae
Lotan, Yair
31675425-4fe7-429a-9292-eb2bd19dad5a
Black, Peter C.
16f69c4b-5aa2-43b8-b179-a5ca2856bb69
Gibb, Ewan A.
0f360aa2-3f90-4f79-9746-00ed593e521e
Porten, Sima P.
8634a772-4d13-486a-82b1-f3f8c0f43ae4

de Jong, Joep J., Boormans, Joost L., van Rhijn, Bas W.G., Seiler, Roland, Boorjian, Stephen A., Konety, Badrinath, Bivalacqua, Trinity J., Wheeler, Thomas, Svatek, Robert S., Douglas, James, Wright, Jonathan, Dall'Era, Marc, Crabb, Simon J., Efstathiou, Jason A, van der Heijden, Michiel S., Mouw, Kent W., Miyamoto, David T., Lotan, Yair, Black, Peter C., Gibb, Ewan A. and Porten, Sima P. (2020) Distribution of molecular subtypes in muscle-invasive bladder cancer is driven by sex-specific differences. European Urology Oncology, 3 (4), 420-423. (doi:10.1016/j.euo.2020.02.010).

Record type: Article

Abstract

Muscle-invasive bladder cancer (MIBC) is a sex-biased cancer with a higher incidence in men but worse outcomes in women. The root cause behind these observations remains unclear. To investigate whether sex-specific tumor biology could explain the differences in clinical behavior of MIBC, we analyzed the transcriptome profiles from transurethral resected bladder tumors of 1000 patients. Female tumors expressed higher levels of basal- and immune-associated genes, while male tumors expressed higher levels of luminal markers. Using molecular subtyping, we found that the rates of the basal/squamous subtype were higher in females than in males. Males were enriched with tumors of the luminal papillary (LumP) and neuroendocrine-like subtypes. Male MIBC tumors had higher androgen response activity across all luminal subtypes and male patients with LumP tumors were younger. Taken together, these data confirm differences in molecular subtypes based on sex. The role of the androgen response pathway in explaining subtype differences between men and women should be studied further.

PATIENT SUMMARY: We explored the sex-specific biology of bladder cancer in 1000 patients and found that women had more aggressive cancer with higher immune activity. Men tended toward less aggressive tumors that showed male hormone signaling, suggesting that male hormones may influence the type of bladder cancer that a patient develops.

This record has no associated files available for download.

More information

Accepted/In Press date: 15 February 2020
e-pub ahead of print date: 20 March 2020
Published date: 1 August 2020
Keywords: Bladder cancer, Gene expression, Molecular subtypes, Sex specific

Identifiers

Local EPrints ID: 441134
URI: http://eprints.soton.ac.uk/id/eprint/441134
PURE UUID: c92747b0-4b52-4de4-b620-02dd16e6083c
ORCID for Simon J. Crabb: ORCID iD orcid.org/0000-0003-3521-9064

Catalogue record

Date deposited: 02 Jun 2020 16:32
Last modified: 11 Jul 2024 01:41

Export record

Altmetrics

Contributors

Author: Joep J. de Jong
Author: Joost L. Boormans
Author: Bas W.G. van Rhijn
Author: Roland Seiler
Author: Stephen A. Boorjian
Author: Badrinath Konety
Author: Trinity J. Bivalacqua
Author: Thomas Wheeler
Author: Robert S. Svatek
Author: James Douglas
Author: Jonathan Wright
Author: Marc Dall'Era
Author: Simon J. Crabb ORCID iD
Author: Jason A Efstathiou
Author: Michiel S. van der Heijden
Author: Kent W. Mouw
Author: David T. Miyamoto
Author: Yair Lotan
Author: Peter C. Black
Author: Ewan A. Gibb
Author: Sima P. Porten

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×